Evidence map›Paper›PMID 28504475›Full record

ArticleAmerican journal of medical genetics. Part C, Seminars in medical genetics2017

MAP3K1-related gonadal dysgenesis: Six new cases and review of the literature.

Andrea Granados, Veronica I Alaniz, Lauren Mohnach, Hayk Barseghyan, Eric Vilain, Harry Ostrer, Elisabeth H Quint, Ming Chen, Catherine E Keegan

Abstract read
In one paragraph

Article in American journal of medical genetics. Part C, Seminars in medical genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Functional Validation of a Novel <italic>PBX1</italic> Missense Variant in a 46,XY Girl.Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation · 2026
    Article
  4. A novel variant in theMolecular medicine reports · 2025
    Article
  5. An Infant WithJCEM case reports · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Identification of a novelMolecular medicine reports · 2022
    Article
  15. Frontiers in genetics · 2022
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Andrea GranadosDepartment of Pediatrics, Division of Endocrinology, University of Michigan, Ann Arbor, Michigan.
Veronica I AlanizDepartment of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan.
Lauren MohnachDisorder of Sex Development Program, University of Michigan, Ann Arbor, Michigan.
Hayk BarseghyanDepartment of Human Genetics, UCLA, Los Angeles, California.
Eric VilainDepartment of Human Genetics, UCLA, Los Angeles, California.
Harry OstrerDepartments of Pathology and Pediatrics, Albert Einstein College of Medicine, Bronx, New York.
Elisabeth H QuintDepartment of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan.
Ming ChenDepartment of Pediatrics, Division of Endocrinology, University of Michigan, Ann Arbor, Michigan.
Catherine E KeeganDepartment of Pediatrics, Division of Genetics and Department of Human Genetics, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0002-7780-6542
University of Michigan · USUniversity of California, Los Angeles · USAlbert Einstein College of Medicine · US

Funding

Disorders of Sex Development: Platform for Basic and Translational ResearchR01HD068138 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SANDBERG, DAVID ERIC, VILAIN, ERIC J. · 2011 to 2015
$4.0M
NICHD NIH HHS R01 HD068138
6 · The paper itself

Abstract

Investigation of disorders of sex development (DSD) has resulted in the discovery of multiple sex-determining genes. MAP3K1 encodes a signal transduction regulator in the sex determination pathway and is emerging as one of the more common genes responsible for 46,XY DSD presenting as complete or partial gonadal dysgenesis. Clinical assessment, endocrine evaluation, and genetic analysis were performed in six individuals from four unrelated families with 46,XY DSD. All six individuals were found to have likely pathogenic MAP3K1 variants. Three of these individuals presented with complete gonadal dysgenesis, characterized by bilateral streak gonads with typical internal and external female genitalia, while the other three presented with partial gonadal dysgenesis, characterized by incomplete testicular development, resulting in clitoral hypertrophy with otherwise typical female external genitalia. Testing for MAP3K1 variants should be considered in patients with 46,XY complete or partial gonadal dysgenesis, particularly in families with multiple members affected with 46,XY DSD. Identification of a MAP3K1 variant should prompt an evaluation for DSD in female siblings of the proband.

Indexed as

AdolescentChildChild, PreschoolDisorder of Sex Development, 46,XYFemaleGonadal DysgenesisHumansMaleMAP Kinase Kinase Kinase 1MutationPedigreeSex DifferentiationMAP3K1 protein, humanMAP Kinase Kinase Kinase 146,XY DSDdisorders of sex developmentgonadal dysgenesisMAP3K1

Identifiers

PMID28504475
PMCPMC5489227
OpenAlexW2615127502

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.